Patents by Inventor Robert Lahti

Robert Lahti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of certain 1-substituted-triazolo-benzodiazepines to treat psychoses
    Patent number: 4472397
    Abstract: Certain 1-(Nitrogen-containing group)-triazolo-benzodiazepines, e.g., adinazolam, are useful for treating psychotic, including schizophrenic, conditions in human patients.
    Type: Grant
    Filed: February 18, 1983
    Date of Patent: September 18, 1984
    Assignee: The Upjohn Company
    Inventors: Robert Lahti, Robert E. Pyke